Oppenheimer Holdings, Inc. (OPY) is a publicly traded Financial Services sector company. As of May 21, 2026, OPY trades at $95.26 with a market cap of $1.01B and a P/E ratio of 10.27. OPY moved +3.01% today. Year to date, OPY is +28.56%; over the trailing twelve months it is +46.10%. Its 52-week range spans $47.39 to $118.77. Rallies surfaces OPY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in OPY news today?
Oppenheimer Upgrades Snowflake to Outperform with $240 Price Target: Oppenheimer analysts upgraded Snowflake to an outperform rating and raised their 12-month price target by 20% to $240, citing stabilizing billings growth after three consecutive quarters of revenue beats. The firm highlighted accelerating enterprise adoption across healthcare and financial services as key drivers of renewed confidence.
McNAMARA DENNIS P sold 4.67K (~$423.70K) on Mar 2, 2026.
Lowenthal Robert S bought 11.28 (~$766.814) on Nov 28, 2025.
LOWENTHAL ALBERT G bought 44.05 (~$2.99K) on Nov 28, 2025.
OPY Analyst Consensus
OPY analyst coverage data. Average price target: $0.00.
Common questions about OPY
What changed in OPY news today?
Oppenheimer Upgrades Snowflake to Outperform with $240 Price Target: Oppenheimer analysts upgraded Snowflake to an outperform rating and raised their 12-month price target by 20% to $240, citing stabilizing billings growth after three consecutive quarters of revenue beats. The firm highlighted accelerating enterprise adoption across healthcare and financial services as key drivers of renewed confidence.
Does Rallies summarize OPY news?
Yes. Rallies summarizes OPY news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is OPY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OPY. It does not provide personalized investment advice.
